Liping Qin, Yajun Li, Ruolan Zeng, Yizi He, Xiaoyan Chen, Ling Xiao, & Hui Zhou. (2024). A novel anti-CD47 antibody with therapeutic potential for NK/T-cell lymphoma. Taylor & Francis Group.
Chicago Style (17th ed.) CitationLiping Qin, Yajun Li, Ruolan Zeng, Yizi He, Xiaoyan Chen, Ling Xiao, and Hui Zhou. A Novel Anti-CD47 Antibody with Therapeutic Potential for NK/T-cell Lymphoma. Taylor & Francis Group, 2024.
MLA (9th ed.) CitationLiping Qin, et al. A Novel Anti-CD47 Antibody with Therapeutic Potential for NK/T-cell Lymphoma. Taylor & Francis Group, 2024.
Warning: These citations may not always be 100% accurate.